Pharmaceutical products, namely, lipid and triglyceride reducing agents used to target or improve the symptoms of hypertriglyceridemia, hypercholesterolema, mixed dyslipidemia, hyperuricemia, atherosclerosis, type 2 diabetes, metabolic syndrome, and microalbuminuria.
ABANDONED SECTION 40(3)
on 18 Aug 2010
XYGLIDE
SHIONOGI IRELAND LIMITED
1357144 · 25 Jul 2007
005
Class 005
Pharmaceutical Products
Pharmaceutical products, namely, lipid and triglyceride reducing agents used to target or improve the symptoms of hypertriglyceridemia, hypercholesterolema, mixed dyslipidemia, hyperuricemia, atherosclerosis, type 2 diabetes, metabolic syndrome, and microalbuminuria.
Pharmaceutical products, namely, lipid and triglyceride reducing agent...
